Clinical Trial Update: Combination Lucentis and Ocular Photodynamic Therapy With Visudyne, With Evaluation-based Retreatment [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the combination of Lucentis (ranibizumab) with ocular photodynamic therapy using Visudyne for Age-Related Macular Degeneration, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Lucentis (ranibizumab)
• Visudyne (verteporfin)

Snippet

Sponsor: Illinois Retina Associates | Conditions: Age-Related Macular Degeneration | Phase 4 | Status: COMPLETED